Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:03:43.081Z.
Calculation as of: 2026-10-06T17:03:43.081Z.
Quote observation: 2026-10-06T17:00:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 66afd7ad6fe085f612ae866be6517f9e897c4fba6e73e474a8e5d595bf17d99d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Parabilis Medicines, Inc.
Market Cap
$3.34B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
Operating Cash Flow Yield
5.74%
TTM Avg
3.90%
3Y Avg
3.98%
5Y Avg
3.98%
Market Cap
$3.40B
Operating Cash Flow Yield
2.76%
TTM Avg
4.26%
3Y Avg
3.12%
5Y Avg
2.89%
Market Cap
$3.41B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Operating Cash Flow Yield
N/A
TTM Avg
0.18%
3Y Avg
0.18%
5Y Avg
0.18%
Market Cap
$3.49B
Operating Cash Flow Yield
N/A
TTM Avg
9.25%
3Y Avg
9.27%
5Y Avg
9.27%
Market Cap
$3.54B
Operating Cash Flow Yield
2.43%
TTM Avg
1.69%
3Y Avg
1.34%
5Y Avg
1.34%
Market Cap
$3.09B
Operating Cash Flow Yield
N/A
TTM Avg
6.43%
3Y Avg
5.84%
5Y Avg
5.84%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.34B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 5.74% | 3.90% | 3.98% | 3.98% |
| CareDx, Inc (CDNA)vs › | $3.40B | 2.76% | 4.26% | 3.12% | 2.89% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | N/A | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.48B | N/A | 0.18% | 0.18% | 0.18% |
| Celcuity Inc. (CELC)vs › | $3.49B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | N/A | 9.25% | 9.27% | 9.27% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | 2.43% | 1.69% | 1.34% | 1.34% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | N/A | 6.43% | 5.84% | 5.84% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.02B | 1.30% | 0.97% | 0.97% | 0.97% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
